Evidence map›Paper›PMID 41968086›Full record

ArticleG3 (Bethesda, Md.)2026

SIN-3 coregulator maintains adaptive capacity to different diets in Caenorhabditis elegans through vitamin B12.

Francesca Palladino, Cécile Bedet

Abstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Francesca PalladinoLaboratory of Biology and Modeling of the Cell, UMR5239 CNRS/Ecole Normale Supérieure de Lyon, INSERM U1210, UMS 3444 Biosciences Lyon Gerland, Université de Lyon, 46 allée d'Italie Lyon 69007, France.ORCID 0000-0003-3087-449X
Cécile BedetLaboratory of Biology and Modeling of the Cell, UMR5239 CNRS/Ecole Normale Supérieure de Lyon, INSERM U1210, UMS 3444 Biosciences Lyon Gerland, Université de Lyon, 46 allée d'Italie Lyon 69007, France.

Funding

ANR (Agence Nationale de la Recherche) 19-CE12-0025-01Center National de la Recherche Scientifique
6 · The paper itself

Abstract

Diet has profound effects on metabolism and health, requiring animals to adapt their physiology to varying food sources. Here we show that the conserved SIN3 transcriptional coregulator is required in Caenorhabditis elegans for animals to adapt to different bacterial diets. Shifting sin-3 mutant animals from the commonly used E. coli  OP50 strain to the E. coli  HT115 strain used for RNAi knockdown experiments has a dramatic impact on survival, leading to the lethality of mutant animals at the young adult stage. A major difference between OP50 and HT115 is vitamin B12 content, which is lower in OP50 than HT115. Feeding sin-3 mutant animals on OP50 bacteria supplemented with vitamin B12 reproduced the lethality observed on HT115. Vitamin B12 functions in 2 metabolic pathways: the canonical propionate breakdown pathway and the methionine/S-adenosylmethionine (met/SAM) cycle. Loss of metr-1, encoding the methionine synthase enzyme that requires vitamin B12 as a cofactor in the met/SAM cycle repressed lethality on HT115. Conversely, complementation with metabolites of the met/SAM cycle enhanced lethality on OP50. These results show that SIN-3 is required for animals to adapt to dietary changes through B12-dependent metabolic pathways.

Indexed as

Adaptation, PhysiologicalCaenorhabditis elegansCaenorhabditis elegans ProteinsDietSin3 Histone Deacetylase and Corepressor ComplexVitamin B 12AnimalsEscherichia coliMethionineMutationRNA InterferenceCaenorhabditis elegans ProteinsMethionineSin3 Histone Deacetylase and Corepressor ComplexVitamin B 12bacterial dietC. elegansSIN-3vitamin B12WormBase

Identifiers

PMID41968086
PMCPMC13232490

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.